Concepedia

Melanie Dujka

MD

Statistics

Publications

9

Citations

554

H-Index

9

Active since

2006

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

University of Houston

Kettering University

Dana-Farber Cancer Institute

Melanie Dujka is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and chromatin.

Top concepts

Publications per year

2006–2022

9

Publications

9

NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells

Claudia P. Miller, Kechen Ban, Melanie Dujka et al. · Blood · 2007 · 203 citations · Full text

Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i> -Mutant Metastatic Breast Cancer

Lillian M. Smyth, Sarina A. Piha‐Paul, Helen Won et al. · Cancer Discovery · 2019 · 108 citations · Full text

DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model

Thang Van Nguyen, Nahum Puebla‐Osorio, Hui Pang et al. · The Journal of Experimental Medicine · 2007 · 72 citations · Full text

Mutations Within the Kinase Domain and Truncations of the Epidermal Growth Factor Receptor Are Rare Events in Bladder Cancer: Implications for Therapy

K. Blehm, Philippe E. Spiess, Jolanta Bondaruk et al. · Clinical Cancer Research · 2006 · 61 citations · Full text

ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo

Melanie Dujka, Nahum Puebla‐Osorio, Omid Tavana et al. · Oncogene · 2009 · 31 citations

, , +12

1–5 of 9